AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL) Sees Large Decrease in Short Interest

AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL – Get Free Report) was the target of a significant decrease in short interest in the month of September. As of September 30th, there was short interest totaling 922,456 shares, a decrease of 36.3% from the September 15th total of 1,447,471 shares. Based on an average daily trading volume, of 588,503 shares, the short-interest ratio is presently 1.6 days. Currently, 3.6% of the shares of the company are sold short.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the stock. Farther Finance Advisors LLC raised its stake in shares of AGF U.S. Market Neutral Anti-Beta Fund by 939.7% during the third quarter. Farther Finance Advisors LLC now owns 42,356 shares of the company’s stock worth $508,000 after purchasing an additional 38,282 shares during the last quarter. CoreCap Advisors LLC acquired a new position in AGF U.S. Market Neutral Anti-Beta Fund in the 2nd quarter valued at $36,000. Crescent Grove Advisors LLC purchased a new position in AGF U.S. Market Neutral Anti-Beta Fund during the 1st quarter worth $6,614,000. Bank of New York Mellon Corp raised its position in AGF U.S. Market Neutral Anti-Beta Fund by 59.4% during the 1st quarter. Bank of New York Mellon Corp now owns 27,235 shares of the company’s stock worth $380,000 after buying an additional 10,146 shares during the last quarter. Finally, Worth Asset Management LLC raised its position in AGF U.S. Market Neutral Anti-Beta Fund by 20.5% during the 1st quarter. Worth Asset Management LLC now owns 30,472 shares of the company’s stock worth $425,000 after buying an additional 5,190 shares during the last quarter.

AGF U.S. Market Neutral Anti-Beta Fund Stock Down 0.2%

NYSEARCA BTAL opened at $12.75 on Friday. AGF U.S. Market Neutral Anti-Beta Fund has a 52-week low of $10.86 and a 52-week high of $16.14. The business’s 50-day moving average price is $12.14 and its 200 day moving average price is $12.14. The firm has a market cap of $325.76 million, a P/E ratio of 17.67 and a beta of -0.65.

AGF U.S. Market Neutral Anti-Beta Fund Company Profile

(Get Free Report)

The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.

Further Reading

Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.